Admissible treatment rules for a risk-averse planner with experimental data on an innovation

Journal of Statistical Planning and Inference

Volumn 137, Issue 6, 2007, Pages 1998-2010

  Manski, Charles F ^a   Tetenov, Aleksey ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Admissibility; Experiments; Minimax regret; Risk aversion; Treatment choice

Indexed keywords

EID: 33846367057     PISSN: 03783758     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jspi.2006.06.037     Document Type: Article

References (9)

1. Canner P. Selecting one of two treatments when the responses are dichotomous. J. Amer. Statist. Assoc. 65 (1970) 293-306
2. Cheng Y., Su F., and Berry D. Choosing sample size for a clinical trial using decision analysis. Biometrika 90 (2003) 923-936
3. Fisher L., and Moyé L. Carvedilol and the food and drug administration approval process: an introduction. Controlled Clinical Trials 20 (1999) 1-15
4. Gould A. Substantial evidence of effect. J. Biopharmaceutical Statist. 12 (2002) 53-77
5. Karlin S., and Rubin H. The theory of decision procedures for distributions with monotone likelihood ratio. Ann. Math. Statist. 27 (1956) 272-299
6. Manski C. Statistical treatment rules for heterogeneous populations. Econometrica 72 (2004) 1221-1246
7. Manski C. Social Choice with Partial Knowledge of Treatment Response (2005), Princeton University Press, Princeton, NJ
8. Stoye J. Minimax-regret treatment choice with finite samples (2005), Department of Economics, New York University, New York, NY
9. Wald A. Statistical Decision Functions (1950), Wiley, New York